INTERPACE BIOSCIENCES, INC. Additional Paid in Capital, Common Stock
INTERPACE BIOSCIENCES, INC. (IDXG) had Additional Paid in Capital, Common Stock of $234.61 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-10
- 2026-06-30: Additional Paid in Capital, Common Stock $234.61M.
- 2026-03-31: Additional Paid in Capital, Common Stock $234.60M.
- 2025-12-31: Additional Paid in Capital, Common Stock $234.83M.
- 2025-09-30: Additional Paid in Capital, Common Stock $234.83M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $234.61M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $234.60M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $234.83M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $234.83M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $234.82M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $234.81M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $234.81M 10-K · filed 2026-03-30 |
| 2024-09-30 | $188.36M 10-K · filed 2025-03-31 |
| 2024-06-30 | $188.28M 10-K · filed 2025-03-31 |
| 2024-03-31 | $188.22M 10-K · filed 2025-03-31 |
| 2023-12-31 | $188.15M 10-K · filed 2025-03-31 |
| 2023-09-30 | $188.02M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $187.87M 10-K · filed 2025-03-31 |
| 2023-03-31 | $187.71M 10-K · filed 2025-03-31 |
| 2022-12-31 | $187.52M 10-K · filed 2024-04-01 |
| 2022-09-30 | $187.39M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $186.82M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $186.49M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $186.11M 10-K · filed 2023-03-27 |
| 2021-09-30 | $186.05M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $185.35M 10-Q · filed 2021-08-11 |
| 2020-12-31 | $184.40M 10-K · filed 2022-03-31 |